Novartis India has approved a Rs 1,250 crore deal to acquire Pfizer's Minipress and Minipress trademarks in India. The deal also includes certain related intellectual property rights. The company’s board approved the transaction...
ProtExtent Biosolutions Pvt Ltd (PBPL), a biotechnology start-up based at the DBT-ILS Bioincubation Centre in Bhubaneswar, is making a strategically important move: the next major opportunity in vaccines may not be captured by producing
Centre’s HPV drive comes under watch as a PIL seeks Supreme Court intervention over consent, safety, and accountability.
.jpg "Why India Needs Global Regulatory Standards to Attract Pharma")
India’s pharma industry is looking beyond generics, but regulatory standards could determine how quickly it attracts global investment in innovation. Commerce and Industry Minister Piyush Goyal has called for greater alignment with developed...
Acquisitions and manufacturing steal the spotlight today as pharma companies pursue strategic deals, capacity expansion, and stronger market reach.
A psychedelic drug could find potential beyond mental health, with researchers exploring psilocybin to prevent chemotherapy-related nerve damage.
Nadda pushes advanced diagnostics at Safdarjung Hospital, adding specialized facilities to strengthen affordable patient care and diagnostic capacity.
Ionis wins FDA approval for the first Alexander disease treatment, offering adults and children a new therapy for this rare disorder.
Medicine overpricing in India has triggered a dispute as drug companies challenge the NPPA’s proposal to shift sole accountability onto manufacturers.
The global race to outpace cancer is accelerating, with MedGenome, HUTCHMED, AbbVie and Cipla advancing detection, treatment, survival and access.
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")